Ocular Therapeutix amends credit agreement to replace LIBOR with SOFR

OCULAR THERAPEUTIX, INC

Amendment dated March 31, 2023 to Fourth Amended and Restated Credit and Security Agreement with MidCap Financial.
Replaces LIBOR-based interest rate provisions with SOFR-based provisions.
Establishes benchmark replacement mechanism and makes administrative updates.
Amendment to be filed as exhibit to Company's Q1 2023 10-Q.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

OCULAR THERAPEUTIX, INC amended Amendment to Fourth Amended and Restated Credit and Security Agreement with MidCap Financial Trust, as administrative agent, and the lenders party thereto (effective 2023-03-31).

Action: amendment
Agreement: credit facility
Counterparty: MidCap Financial Trust, as administrative agent, and the lenders party thereto
Effective: 2023-03-31

Exact text from the filing

the Company, the Administrative Agent, and the Lenders entered into an amendment to the Agreement on March 31, 2023 (the “Amendment”), to replace the LIBOR-based interest rate provisions of the Agreement with SOFR-based interest rate provisions, establish a benchmark replacement mechanism and make additional administrative updates.

View on SEC.gov

Browse all material agreements →

OCULAR THERAPEUTIX, INC filing history →

Source: SEC EDGAR

accession 0001104659-23-042710

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.